Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-009568

President & CEO gave up 43,224 shares (to pay taxes)

  • President & CEO acquired 56,949 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stonehouse Jon P · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-28 Exercise or conversion : show line 1 in the form +56,949 $3.26 $185,654 698,316 D
2018-02-28 Shares withheld for taxes : show line 2 in the form −43,224 $4.97 $214,823 655,092 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-02-28 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −56,949 0 D
Loading xslF345X03/form4.xml…